Stay updated on SAR425899 Safety in Overweight Type 2 Diabetes Clinical Trial
Sign up to get notified when there's something new on the SAR425899 Safety in Overweight Type 2 Diabetes Clinical Trial page.

Latest updates to the SAR425899 Safety in Overweight Type 2 Diabetes Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.3%
- Check28 days agoNo Change Detected
- Check35 days agoChange DetectedThe page has been updated to reflect a new version, changing from v2.14.4 to v2.15.0.SummaryDifference1.0%
- Check42 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.3%
- Check86 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference5%
- Check100 days agoChange DetectedThe page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with a contact email for assistance.SummaryDifference5%
- Check107 days agoChange DetectedThe website has been updated from version 2.14.1 to 2.14.2.SummaryDifference0.3%
Stay in the know with updates to SAR425899 Safety in Overweight Type 2 Diabetes Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SAR425899 Safety in Overweight Type 2 Diabetes Clinical Trial page.